302 related articles for article (PubMed ID: 17062918)
1. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918
[TBL] [Abstract][Full Text] [Related]
2. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
4. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
5. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
6. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
7. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
8. Dimethylarginine levels and nutritional status in hemodialysis patients.
Cupisti A; Saba A; D'Alessandro C; Meola M; Panicucci E; Panichi V; Raffaelli A; Barsotti G
J Nephrol; 2009; 22(5):623-9. PubMed ID: 19809995
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between serum asymmetric dimethylarginine and blood pressure in patients with chronic renal failure].
Zhang WR; Tao LJ; Chen BM
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):133-4. PubMed ID: 12575339
[TBL] [Abstract][Full Text] [Related]
10. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.
Maas R; Xanthakis V; Polak JF; Schwedhelm E; Sullivan LM; Benndorf R; Schulze F; Vasan RS; Wolf PA; Böger RH; Seshadri S
Stroke; 2009 Aug; 40(8):2715-9. PubMed ID: 19498184
[TBL] [Abstract][Full Text] [Related]
11. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
Sen N; Poyraz F; Tavil Y; Yazici HU; Turfan M; Hizal F; Topal S; Erdamar H; Cakir E; Yalçin R; Cengel A
Atherosclerosis; 2009 Jun; 204(2):e82-5. PubMed ID: 19010468
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.
Fleck C; Schweitzer F; Karge E; Busch M; Stein G
Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
15. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
[TBL] [Abstract][Full Text] [Related]
16. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
Jepson RE; Syme HM; Vallance C; Elliott J
J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
[TBL] [Abstract][Full Text] [Related]
17. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
18. Levels of arginine and its products in dialysis patients.
Ugurcu V; Vatansev H; Unlu A; Sivrikaya A; Akyurek F; Ozturk B; Kiyici A; Erdem SS
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2357-64. PubMed ID: 25219838
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S
J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
Fliser D; Kronenberg F; Kielstein JT; Morath C; Bode-Böger SM; Haller H; Ritz E
J Am Soc Nephrol; 2005 Aug; 16(8):2456-61. PubMed ID: 15930091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
